CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease
Open Access
- 15 March 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 97 (6), 1543-1548
- https://doi.org/10.1182/blood.v97.6.1543
Abstract
Lymph nodes with Hodgkin disease (HD) harbor few neoplastic cells in a marked leukocytic infiltrate. Since chemokines are likely to be involved in the recruitment of these leukocytes, the expression of potentially relevant chemokines and chemokine receptors were studied in lymph nodes from 24 patients with HD and in 5 control lymph nodes. The expression of regulated on activation, normal T cell expressed and secreted (RANTES), monocyte chemotactic protein (MCP)–1, macrophage inflammatory protein (MIP)–1α, and MIP-1β was analyzed by in situ hybridization and that of CCR3 and CCR5 by immunohistochemistry and flow cytometry. It was found that, overall, the expression of all 4 chemokines was markedly enhanced, but the cellular source was different. RANTES was expressed almost exclusively by T cells whereas the expression of MCP-1, MIP-1α, and MIP-1β was confined largely to macrophages. In control lymph nodes, chemokine expression was low, with the exception of MIP-1α in macrophages. CCR3 and CCR5 were highly expressed in T cells of HD involved but not of control lymph nodes. CCR3 was equally distributed in CD4+ and CD8+ cells, but CCR5 was associated largely with CD4+ cells. In HD lymph nodes, CCR3 and CCR5 were also expressed in B cells, which normally do not express these receptors. All these chemokines and receptors studied, by contrast, were absent in the neoplastic cells. It was concluded that chemokines are involved in the formation of the HD nonneoplastic leukocytic infiltrate. Expression of CCR3 and CCR5 appears to be characteristic of HD, but the roles of these receptors' up-regulation for the disease process remain unclear.This publication has 32 references indexed in Scilit:
- High Expression of the CC Chemokine TARC in Reed-Sternberg Cells: A Possible Explanation for the Characteristic T-Cell Infiltrate in Hodgkin's LymphomaThe American Journal of Pathology, 1999
- Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.The Journal of Experimental Medicine, 1996
- Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin.The Journal of Experimental Medicine, 1996
- Cloning, expression, and characterization of the human eosinophil eotaxin receptor.The Journal of Experimental Medicine, 1996
- RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells.The Journal of Experimental Medicine, 1996
- Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.JCI Insight, 1996
- Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiencyEuropean Journal of Immunology, 1994
- Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.The Journal of Experimental Medicine, 1994
- Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.The Journal of Experimental Medicine, 1993
- A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor.The Journal of Experimental Medicine, 1988